Europe Hyaluronic Acid Market Size & Outlook, 2026-2033
- Pharmaceuticals
- Active Pharmaceuticals Ingredients & Excipients
- Hyaluronic Acid Market Outlook
- Active Pharmaceuticals Ingredients & Excipients
Global Market
Related Markets
Ask a question about the hyaluronic acid market
Europe hyaluronic acid market highlights
- The Europe hyaluronic acid market generated a revenue of USD 3,177.4 million in 2025.
- The market is expected to grow at a CAGR of 7.4% from 2026 to 2033.
- In terms of segment, dermal fillers was the largest revenue generating application in 2025.
- Dermal Fillers is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Norway is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 3,177.4 million |
| Market revenue in 2033 | USD 5,606.6 million |
| Growth rate | 7.4% (CAGR from 2026 to 2033) |
| Largest segment | Dermal fillers |
| Fastest growing segment | Dermal Fillers |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dermal Fillers, Vesicoureteral Reflux, Osteoarthritis, Ophthalmic |
| Key market players worldwide | Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology |
Other key industry trends
- In terms of revenue, Europe region accounted for 27.6% of the global hyaluronic acid market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,144.8 million by 2033.
In Europe, the market is witnessing a shift from multiple-injection cycle products to single-injection for osteoarthritis treatment, owing to greater convenience provided by single-injection products.
It is also expected that due to higher relative cost-benefit provided by single-injection treatment, the threeinjection treatment segment will lose part of its share to single-injection treatments.
Moreover, less stringent regulatory framework for hyaluronic acid-based product approval is expected to drive the market in Europe. Osteoporosis affects more than 2.5 million women in both the UK and France every year.
No credit card required*
Publish Date: Jun 05, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hyaluronic Acid Market Scope
Hyaluronic Acid Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| Nestle SA | View profile | 270,000 | Avenue Nestle 55, Vevey, Switzerland, CH-1800 | www.nestle.com |
| Zimmer Biomet Holdings Inc | View profile | 18,000 | 345 East Main Street, Warsaw, IN, United States, 46580 | www.zimmerbiomet.com |
| Shiseido Co Ltd | View profile | 35,859 | 5-5 Ginza 7-chome, Chuo-ku, Tokyo, Japan, 104-0061 | www.shiseido.co.jp |
| Allergan | View profile | 10001+ | Madison, Wisconsin, United States, North America | www.allergan.com |
| Smith & Nephew PLC | View profile | 18,452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | www.smith-nephew.com |
| LG Chem | View profile | 10001+ | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | www.lgchem.com |
| Anika Therapeutics Inc | View profile | 357 | 32 Wiggins Avenue, Bedford, MA, United States, 01730 | www.anika.com |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | www.ferring.com |
Europe Hyaluronic Acid Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Hyaluronic Acid Market Outlook will help companies and investors design strategic landscapes.
Dermal Fillers was the largest segment with a revenue share of 55.37% in 2025.
Horizon Databook has segmented the Europe hyaluronic acid market based on dermal fillers, vesicoureteral reflux, osteoarthritis, ophthalmic covering the revenue growth of each sub-segment from 2021 to 2033.
In Europe, the market is witnessing a shift from multiple-injection cycle products to single-injection for osteoarthritis treatment, owing to greater convenience provided by single-injection products.
It is also expected that due to higher relative cost-benefit provided by single-injection treatment, the threeinjection treatment segment will lose part of its share to single-injection treatments.
Moreover, less stringent regulatory framework for hyaluronic acid-based product approval is expected to drive the market in Europe. Osteoporosis affects more than 2.5 million women in both the UK and France every year.
- Europe Hyaluronic Acid Market Application Outlook (Revenue, USD Million , 2021-2033)
- Dermal Fillers
- Osteoarthritis
- Ophthalmic
- Vesicoureteral Reflux
Reasons to subscribe to Hyaluronic Acid Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Hyaluronic Acid Market Outlook databook
- Our clientele includes a mix of Hyaluronic Acid Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Hyaluronic Acid Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Hyaluronic Acid Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Hyaluronic Acid Market, 2021-2033 (US$M)
Europe Application - Hyaluronic Acid Market Statistics, 2025 - 2033 (US$M)
